| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Division of Clinical and Molecular Endocrinology, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4951; and the Department of Cancer Biology at the Cleveland Clinic Research Institute (S.C.E.), Cleveland, Ohio 44195
Address all correspondence and requests for reprints to: Dr. Marc Thibonnier, Room BRB431, Division of Clinical and Molecular Endocrinology, Department of Medicine, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland, Ohio 44106-4951. E-mail: mxt10{at}po.cwru.edu
Pharmacological studies in humans and animals suggest the existence of vascular endothelial vasopressin (AVP)/oxytocin (OT) receptors that mediate a vasodilatory effect. However, the nature of the receptor subtype(s) involved in this vasodilatory response remains controversial, and its coupled intracellular pathways are unknown. Thus, we set out to determine the type and signaling pathways of the AVP/OT receptor(s) expressed in human vascular endothelial cells (ECs).
Saturation binding experiments with purified membranes of primary cultures of ECs from human umbilical vein (HUVEC), aorta (HAEC), and pulmonary artery (HPAEC) and [3H]AVP or [3H]OT revealed the existence of specific binding sites with a greater affinity for OT than AVP (Kd = 1.75 vs. 16.58 nM). Competition binding experiments in intact HUVECs (ECV304 cell line) with the AVP antagonist [125I]4-hydroxyphenacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2 or the OT antagonist [125I]D(CH2)5[O-Me-Tyr-Thr-Orn-Tyr-NH2]vasotocin, and various AVP/OT analogs confirmed the existence of a single class of surface receptors of the classical OT subtype.
RT-PCR experiments with total RNA extracted from HUVEC, HAEC, and HPAEC and specific primers for the human V1 vascular, V2 renal, V3 pituitary, and OT receptors amplified the OT receptor sequence only. No new receptor subtype could be amplified when using degenerate primers. DNA sequencing of the coding region of the human EC OT receptor revealed a nucleotide sequence 100% homologous to that of the uterine OT receptor reported previously.
Stimulation of ECs by OT produced mobilization of intracellular calcium and the release of nitric oxide that was prevented by chelation of extra- and intracellular calcium. No stimulation of cAMP or PG production was noted. Finally, OT stimulation of ECs led to a calcium- and protein kinase C-dependent cellular proliferation response.
Thus, human vascular ECs express OT receptors that are structurally identical to the uterine and mammary OT receptors. These endothelial OT receptors produce a calcium-dependent vasodilatory response via stimulation of the nitric oxide pathway and have a trophic action.
This article has been cited by other articles:
![]() |
E. Langesaeter, L. A. Rosseland, and A. Stubhaug Haemodynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients Br. J. Anaesth., August 1, 2009; 103(2): 260 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Szeto, D. A. Nation, A. J. Mendez, J. Dominguez-Bendala, L. G. Brooks, N. Schneiderman, and P. M. McCabe Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1495 - E1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Holt-Lunstad, W. A. Birmingham, and K. C. Light Influence of a "Warm Touch" Support Enhancement Intervention Among Married Couples on Ambulatory Blood Pressure, Oxytocin, Alpha Amylase, and Cortisol Psychosom Med, November 1, 2008; 70(9): 976 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Teruyama, D. L. Lipschitz, L. Wang, G. R. Ramoz, W. R. Crowley, S. L. Bealer, and W. E. Armstrong Central blockade of oxytocin receptors during mid-late gestation reduces amplitude of slow afterhyperpolarization in supraoptic oxytocin neurons Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1167 - E1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gutkowska, M. Miszkurka, B. Danalache, N. Gassanov, D. Wang, and M. Jankowski Functional arginine vasopressin system in early heart maturation Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2262 - H2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Reversi, V. Rimoldi, S. Brambillasca, and B. Chini Effects of cholesterol manipulation on the signaling of the human oxytocin receptor Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R861 - R869. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cassoni, T. Marrocco, B. Bussolati, E. Allia, L. Munaron, A. Sapino, and G. Bussolati Oxytocin Induces Proliferation and Migration in Immortalized Human Dermal Microvascular Endothelial Cells and Human Breast Tumor-Derived Endothelial Cells Mol. Cancer Res., June 1, 2006; 4(6): 351 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lollivier, P.-G. Marnet, S. Delpal, D. Rainteau, C. Achard, A. Rabot, and M. Ollivier-Bousquet Oxytocin stimulates secretory processes in lactating rabbit mammary epithelial cells J. Physiol., January 1, 2006; 570(1): 125 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Devost, M. Girotti, M.-E. Carrier, C. Russo, and H. H. Zingg Oxytocin Induces Dephosphorylation of Eukaryotic Elongation Factor 2 in Human Myometrial Cells Endocrinology, May 1, 2005; 146(5): 2265 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vignozzi, G. B. Vannelli, A. Morelli, R. Mancina, M. Marini, P. Ferruzzi, C. Crescioli, M. Luconi, S. Donati, A. D. Fisher, et al. Identification, characterization and biological activity of oxytocin receptor in the developing human penis Mol. Hum. Reprod., February 1, 2005; 11(2): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamaguchi, K. Yamada, T. Suzuki, Y.-P. Wu, K. Kita, S. Takahashi, M. Ichinose, and N. Suzuki Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP) Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E970 - E976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jankowski, B. Danalache, D. Wang, P. Bhat, F. Hajjar, M. Marcinkiewicz, J. Paquin, S. M. McCann, and J. Gutkowska Oxytocin in cardiac ontogeny PNAS, August 31, 2004; 101(35): 13074 - 13079. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsuura, T. Nagai, N. Nishigaki, T. Oyama, J. Nishi, H. Wada, M. Sano, H. Toko, H. Akazawa, T. Sato, et al. Adult Cardiac Sca-1-positive Cells Differentiate into Beating Cardiomyocytes J. Biol. Chem., March 19, 2004; 279(12): 11384 - 11391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. ANTUNES-RODRIGUES, M. DE CASTRO, L. L. K. ELIAS, M. M. VALENCA, and S. M. McCANN Neuroendocrine Control of Body Fluid Metabolism Physiol Rev, January 1, 2004; 84(1): 169 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Jeng, S. L. Soloff, G. D. Anderson, and M. S. Soloff Regulation of Oxytocin Receptor Expression in Cultured Human Myometrial Cells by Fetal Bovine Serum and Lysophospholipids Endocrinology, January 1, 2003; 144(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, J. Gutkowska, M. Marcinkiewicz, G. Rachelska, and M. Jankowski Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats Cardiovasc Res, January 1, 2003; 57(1): 186 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-M. Trinh-Trang-Tan, F. Lasbennes, P . Gane, N. Roudier, P. Ripoche, J.-P. Cartron, and P. Bailly UT-B1 proteins in rat: tissue distribution and regulation by antidiuretic hormone in kidney Am J Physiol Renal Physiol, November 1, 2002; 283(5): F912 - F922. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.C. Weston, I. Haviv, and P.A.W. Rogers Microarray analysis of VEGF-responsive genes in myometrial endothelial cells Mol. Hum. Reprod., September 1, 2002; 8(9): 855 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Paquin, B. A. Danalache, M. Jankowski, S. M. McCann, and J. Gutkowska Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes PNAS, July 9, 2002; 99(14): 9550 - 9555. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cassoni, A. Sapino, S. Deaglio, B. Bussolati, M. Volante, L. Munaron, A. Albini, A. Torrisi, and G. Bussolati Oxytocin Is a Growth Factor for Kaposi's Sarcoma Cells: Evidence of Endocrine-Immunological Cross-Talk Cancer Res., April 1, 2002; 62(8): 2406 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Miller, S. T. Davidge, and B. F. Mitchell Oxytocin does not directly affect vascular tone in vessels from nonpregnant and pregnant rats Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1223 - H1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Holmes, B. M. Patel, J. A. Russell, and K. R. Walley Physiology of Vasopressin Relevant to Management of Septic Shock Chest, September 1, 2001; 120(3): 989 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukaddam-Daher, Y.-L. Yin, J. Roy, J. Gutkowska, and R. Cardinal Negative Inotropic and Chronotropic Effects of Oxytocin Hypertension, August 1, 2001; 38(2): 292 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bussolati and P. Cassoni Editorial: The Oxytocin/Oxytocin Receptor System--Expect the Unexpected Endocrinology, April 1, 2001; 142(4): 1377 - 1379. [Full Text] |
||||
![]() |
G. Gimpl and F. Fahrenholz The Oxytocin Receptor System: Structure, Function, and Regulation Physiol Rev, April 1, 2001; 81(2): 629 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cassoni, A. Sapino, L. Munaron, S. Deaglio, B. Chini, A. Graziani, A. Ahmed, and G. Bussolati Activation of Functional Oxytocin Receptors Stimulates Cell Proliferation in Human Trophoblast and Choriocarcinoma Cell Lines Endocrinology, March 1, 2001; 142(3): 1130 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakamura, A. Itakuara, M. Okamura, M. Ito, A. Iwase, Y. Nakanishi, M. Okada, T. Nagasaka, and S. Mizutani Oxytocin Stimulates the Translocation of Oxytocinase of Human Vascular Endothelial Cells Via Activation of Oxytocin Receptors Endocrinology, December 1, 2000; 141(12): 4481 - 4485. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Novak, M. B. Judkins, M. I. Chernin, P. Cassoni, G. Bussolati, J. A. Nitche, and S. K. Nishimoto A Plasmin-derived Hexapeptide from the Carboxyl End of Osteocalcin Counteracts Oxytocin-mediated Growth of Inhibition of Osteosarcoma Cells Cancer Res., July 1, 2000; 60(13): 3470 - 3476. [Abstract] [Full Text] |
||||
![]() |
M. Jankowski, D. Wang, F. Hajjar, S. Mukaddam-Daher, S. M. McCann, and J. Gutkowska Oxytocin and its receptors are synthesized in the rat vasculature PNAS, May 23, 2000; 97(11): 6207 - 6211. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |